Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015

 

Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 

 
 
 
 

Recommended Videos

Behind the Science, S3 Ep 1: Exploring new dimensions in chromatography with Claude Mallet

Video

To kick off season 3 of Behind the Science, our host Jen Fournier meets Claude Mallet of Waters at his new multi-dimensional chromatography lab to break down the myths of 2D LC, also known as LCxLC.

WATCH NOW

Claisse® LeDoser 12™ Instrument - Just-in-time weighing for optimal precision and repeatability!

Video

LeDoser-12 is a robust instrument that does not get tired or distracted; it can work in harsh work conditions and always provides the same repeatability.

WATCH NOW

Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Video

Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy